360 High-Risk Vulnerability Immunization Tool V2.0 vs Internxt Antivirus: Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

Internxt Antivirus: Antivirus software for malware detection and removal on Windows, Mac, and Linux. built by Internxt. Core capabilities include Malware detection and removal, Full system scanning, Custom file scanning..

Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.

360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. Internxt Antivirus differentiates with Malware detection and removal, Full system scanning, Custom file scanning.

360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). Internxt Antivirus is developed by Internxt. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.

360 High-Risk Vulnerability Immunization Tool V2.0 and Internxt Antivirus serve similar Endpoint Protection Platform use cases: both are Endpoint Protection Platform tools, both cover Windows Security. Review the feature comparison above to determine which fits your requirements.